Menu Menu

KYMR    Kymera Therapeutics Inc    1815442    
Income Statement
Revenue kymr-20240930 3,741,000
Net Income kymr-20240930 -62,487,000
Profit Margin -1670.33%

Balance Sheet
Current Assets 568,715,000
Assets 1,034,842,000
Current Liabilities 66,532,000
Liabilities 141,912,000
Equity 892,930,000
Shares Out 63,756,000

Cash Flow Statement
Operating Cash Flow -132,717,000
Investing Cash Flow -472,645,000

Market Analysis
Market Cap 3,092,949,370
Price 40.61
BVPS 14.01
PB 2.90
EPS -2.41
PS 206.69
FCF -605,362,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/22 -0.25
Apr May Jun
5/02 -0.69
Jul Aug Sep
8/07 -0.58
Oct Nov Dec
10/31 -0.82

Find a discrepancy? The most accurate way to find company fundamental data is to view KYMR documents filed with the SEC.


KYMR Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas